Cipla to acquire 51% stake in Uganda's Quality Chemicals

Last Updated: Friday, May 22, 2015, 17:33

Cipla shares today ended at Rs 674.05 apiece on the BSE, down 0.05 percent from previous close.

Cipla recalls over 1.4 lakh vials of asthma drug in US

Last Updated: Thursday, May 21, 2015, 16:04

Drug major Cipla is recalling in the US market 1,40,625 vials of Levalbuterol Inhalation Solution used for relieving shortness of breath and coughing caused by asthma and chronic obstructive pulmonary disease.

Cipla promoters to decide on family pact in 'due course'

Last Updated: Sunday, May 10, 2015, 12:16

Sebi has opined that the agreement would qualify for exemption from open offer requirement under takeover norms.

Cipla promoter family gets SEBI go-ahead for voting agreement

Last Updated: Tuesday, May 5, 2015, 23:13

In a possible succession planning exercise, pharma giant Cipla's promoter family has proposed to vote together as a single unit under overall direction of patriarch Yusuf Hamied in his lifetime, and under his brother Mustafa Hamied thereafter.

Ready to pay "reasonable" royalty to Novartis AG: Cipla to HC

Last Updated: Monday, April 27, 2015, 23:21

Indian pharma firm Cipla Monday suggested to the Delhi High Court that it was ready to pay "reasonable" royalty to Switzerland-based drug major Novartis AG if it is allowed to manufacture respiratory disease drug, 'Indaflo', which could serve 66,000 patients in India at a cheaper rate.

Cipla to acquire Brazil's Duomed Produtos for Rs 2.6 crore

Last Updated: Thursday, April 9, 2015, 11:42

Pharma major Cipla on Thursday said its UK subsidiary Cipla (EU) will acquire Brazilian firm Duomed Produtos Farmaceuticos for about Rs 2.6 crore.

Cipla to launch generic Hepatitis C drug 'Hepcvir' in India

Last Updated: Wednesday, March 25, 2015, 15:37

Drug major Cipla on Wednesday announced the launch of generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name 'Hepcvir', in India.

Cipla to form JV with Biopharm SPA for respiratory products

Last Updated: Friday, February 13, 2015, 12:25

Pharmaceutical firm Cipla Ltd has entered into an agreement with Biopharm SPA to form a joint venture company in Algeria to manufacture and market respiratory products, the company said Friday.

Cipla Q3 Net up 15% at Rs 328 cr; to buy 60% in Jay Precision

Last Updated: Thursday, February 12, 2015, 21:56

Pharmaceutical firm Cipla Ltd on Thursday reported 15.31 percent increase in its consolidated net profit at Rs 327.85 crore in the third quarter ended December 31, 2014.

Cipla forms JV in Morocco to enhance position in African market

Last Updated: Monday, February 9, 2015, 18:56

Cipla (EU) Ltd, UK, a wholly-owned subsidiary of Mumbai-based drug firm, has inked the JV agreement with the Moroccan entities.

Hamied family co buys out minority shareholders in Okasa

Last Updated: Wednesday, January 14, 2015, 21:55

Hamsons, a firm owned by the promoter family of pharma major Cipla, has bought out the remaining 21 per cent equity owned by minority shareholders in Satara-based Okasa Pharma for an undisclosed amount, completing the process it started last September.

Cipla moves HC against restraint on its Indacaterol-based drug

Last Updated: Tuesday, January 13, 2015, 18:24

The matter was mentioned before a bench of Justices Badar Durrez Ahmed and Sanjeev Sachdeva who directed that the plea be listed before the appropriate bench tomorrow.